Centre Unveils World’s First Made-In-India Covid Nasal Vaccine 'iNCOVACC' By Bharat BiotechSwarajya StaffThursday, January 26, 2023 06:25 PM IST
Bharat Biotech's Intranasal COVID-19 Vaccine To Cost Rs 800 For Private Markets, Rs 325 For Govt SuppliesPTITuesday, December 27, 2022 02:00 PM IST
Centre Signs PPP With Bharat Biotech For Development Plus Commercial Production Of Intranasal Covid-19 And Malaria VaccinesSwarajya StaffSunday, March 27, 2022 01:51 PM IST
Bharat Biotech Gets DCGI Nod For Phase 3 Trials Of Its Intra-Nasal COVID-19 VaccinePTIFriday, January 28, 2022 04:16 PM IST
Omicron Is Behaving More Rationally Than Politicians And Media, Who Are Part Of The ProblemR JagannathanThursday, January 6, 2022 04:24 PM IST
Bharat Biotech Gets DCGI Panel's Approval For Phase 3 Trials Of Intranasal COVID-19 Vaccine As Booster Shot: ReportSwarajya StaffWednesday, January 5, 2022 05:29 PM IST
Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna EllaBhaswati Guha Majumder Monday, November 29, 2021 06:23 PM IST
UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International TravellersSwarajya StaffTuesday, November 23, 2021 10:53 AM IST
Lost 10 Years Of Life In Past 18 Months Due To Stress And Excitement Of Developing Covaxin: Dr Krishna Ella Swarajya StaffSunday, November 14, 2021 08:57 AM IST
Bharat Biotech Chairman Dr Krishna Ella Slams Biased Media Coverage And Domestic Politics Around Covaxin: "It Really Hurts"Swarajya StaffFriday, November 12, 2021 03:34 PM IST
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In LancetSwarajya StaffFriday, November 12, 2021 10:05 AM IST
Booster Doses? Vaccination For Children? SUTRA Team Answers Your QuestionsThe SUTRA TeamWednesday, November 10, 2021 11:43 AM IST
Zydus Cadila To Enter Vaccine Space By Supplying 1 Crore Of Its Plasmid DNA Vaccine Shots To Centre; Read Other Details HereBhaswati Guha Majumder Tuesday, November 9, 2021 12:57 PM IST
US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical TrialsBhaswati Guha Majumder Thursday, October 28, 2021 02:33 PM IST
WHO Seeks 'Additional Clarifications' From Bharat Biotech For Covaxin To Conduct Final 'Risk-Benefit Assessment'
PTIWednesday, October 27, 2021 09:54 AM IST
What Can Possibly Explain WHO's Delay In Approving Covaxin?Bhaswati Guha Majumder Wednesday, October 20, 2021 07:16 PM IST
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The PipelineBhaswati Guha Majumder Wednesday, October 13, 2021 01:00 PM IST
GSK-Bharat Biotech Partnership To Produce World's First Malaria Vaccine Approved By WHOSwarajya StaffFriday, October 8, 2021 10:33 AM IST
Final Decision On Approval To Bharat Biotech's Covaxin To Be Taken Next Week: WHOSwarajya StaffWednesday, October 6, 2021 10:38 AM IST
India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: ReportSwarajya StaffFriday, October 1, 2021 10:32 AM IST